Imaging3 appoints law firm to aid Dominion approval
This article was originally published in Clinica
Imaging3 has appointed international law firm McDermott Will & Emery as an FDA consultant, hoping that this will aid the approval of its troubled Dominion 3D scanner. Last week the US FDA rejected the firm's 510(k) application for the device, sending its shares plunging to almost half their value (www.clinica.co.uk, 3 November 2010). At the time, Burbank, California-based Imaging3 said the decision "did not make any sense", adding that it planned to hire a "big hitter" in the consulting or legal field to try and get the product approved.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.